EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders

Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry, Ashish Garg, Nitish Kumar, Madhu Gupta, Sanjeeb Kumar Kar, Anas Islam, Sourav Mohanto, Vetriselvan Subramaniyan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-01 · 398 (1) · 417-448

DOI: 10.1007/s00210-024-03392-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 28.08.2024. Verfasst von Sumel Ashique und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, 713212, India. ashiquesumel007@gmail.com. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Lung Diseases, Inflammation, Inflammation Mediators. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 364 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A significant number of deaths and disabilities worldwide are brought on by inflammatory lung diseases. Many inflammatory lung disorders, including chronic respiratory emphysema, resistant asthma, resistance to steroids, and coronavirus-infected lung infections, have severe variants for which there are no viable treatments; as a result, new treatment alternatives are needed. Here, we emphasize how oxidative imbalance contributes to the emergence of provocative lung problems that are challenging to treat. Endogenic antioxidant systems are not enough to avert free radical-mediated damage due to the induced overproduction of ROS. Pro-inflammatory mediators are then produced due to intracellular signaling events, which can harm the tissue and worsen the inflammatory response. Overproduction of ROS causes oxidative stress, which causes lung damage and various disease conditions. Invasive microorganisms or hazardous substances that are inhaled repeatedly can cause an excessive amount of ROS to be produced. By starting signal transduction pathways, increased ROS generation during inflammation may cause recurrent DNA damage and apoptosis and activate proto-oncogenes. This review provides information about new targets for conducting research in related domains or target factors to prevent, control, or treat such inflammatory oxidative stress-induced inflammatory lung disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesLung DiseasesInflammationInflammation MediatorsHumansOxidative StressAnimalsDisease ProgressionSignal Transduction

Stichwörter der Autor:innen

BiochemicalInflammationLung disordersOxidative stressReactive oxygen speciesToxicity

Substanzen

Reactive Oxygen SpeciesInflammation Mediators

Autor:innen und Institutionen

  • Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, 713212, India. ashiquesumel007@gmail.com.
  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India. ashiquesumel007@gmail.com.
  • Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior, MP, 474005, India.
  • Department of Pharmaceutics, Department of Pharmacy, Sarala Birla University, Ranchi, Jharkhand, 835103, India.
  • Department of Pharmaceutics, Guru Ramdas Khalsa Institute of Science and Technology (Pharmacy), Jabalpur, Madhya Pradesh, 483001, India.
  • SRM Modinagar College of Pharmacy, SRM Institute of Science and Technology (Deemed to Be University), Delhi-NCR Campus, Modinagar, Ghaziabad, Uttar Pradesh, 201204, India.

Zitieren

APA

Ashique, S., Mishra, N., Mantry, S., Garg, A., Kumar, N., Gupta, M., Kar, S. K., Islam, A., Mohanto, S., & Subramaniyan, V. (2025). Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(1), 417-448. https://doi.org/10.1007/s00210-024-03392-1

Vancouver

Ashique S, Mishra N, Mantry S, Garg A, Kumar N, Gupta M, et al. Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(1):417-448. doi:10.1007/s00210-024-03392-1

BibTeX
@article{Ashique2025,
  author = {Ashique, Sumel and Mishra, Neeraj and Mantry, Shubhrajit and Garg, Ashish and Kumar, Nitish and Gupta, Madhu and Kar, Sanjeeb Kumar and Islam, Anas and Mohanto, Sourav and Subramaniyan, Vetriselvan},
  title = {Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {1},
  pages = {417--448},
  doi = {10.1007/s00210-024-03392-1}
}
Kostenlos starten →